Effect of Helicobacter pylori infection on antral gastrin and somatostatin cells and on serum gastrin concentrations

Article information

Korean J Intern Med. 1999;14(1):15-20

doi : https://doi.org/10.3904/kjim.1999.14.1.15

Sill Moo Park ^*^,, Hyo Rang Lee ^*, Jae Gyu Kim ^*, Joong Won Park ^*, Gyu Jung ^*, Seong Hyuck Han ^*, Joon Hyung Cho ^*, Mi Kyung Kim ⁺

^*Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Korea

⁺Department of Pathology, College of Medicine, Chung-Ang University, Seoul, Korea

Address reprint requests to: Dr Sill Moo Park, Department of Internal Medicine, Chung-Ang University, Yong-San Hospital, 65-207, Hangang-Ro 3-Ka, Yongsan-Ku. Seoul 140-757, Korea

Abstract

Objectives

Helicobacter pylori infection induces selective reduction of the number of antral D-cells and results in abnormal regulation of serum gastrin secretion. The purpose of this study was to investigate the relationship between H. pylori infection and the numbers of G-cells and D-cells.

Methods

The numbers of antral G-cells and D-cells, the ratio of G-cells to D-cells and fasting serum gastrin concentrations were compared between 37 patients with (29 with duodenal ulcers and 8 with gastric ulcers) and 33 without H. pylori infection (22 with duodenal ulcers and 11 with gastric ulcers). Serum gastrin concentrations were measured using the radioimmunoassay technique. Antral mucosal biopsy specimens were examined using immunohistochemical staining with antibodies specific for gastrin and somatostatin and the numbers of G-cells and D-cells per gastric gland were counted.

Results

Fasting serum gastrin concentrations were significantly higher in patients with H. pylori infection compared to patients without infection (80.3±23.5 vs 47.6±14.1 pg/ml, p<0.001). The number of G-cells per gastric gland was similar in infected and uninfected patients (7.1±3.1 vs 7.3±3.9, respectively, p>0.5). The number of D-cells was significantly lower in patients with H. pylori infection than in uninfected patients in both duodenal and gastric ulcer patients (1.3±0.4 vs 2.5±1.6, respectively, p<0.001). The ratio of G-cells to D-cells was also significantly higher in infected patients compared with uninfected patients for both gastric and duodenal ulcers (5.7±2.7 vs 3.5±1.9, respectively, p<0.001).

Conclusions

These results strongly suggest that Helicobacter pylori infection induces reduction of the number of antral D-cells. The resulting relative hypofunction of the inhibitory action of D-cells against G-cells may be responsible for increased serum gastrin secretion.

Keywords: H. pylori; G-cells; D-cells; Gastrin

INTRODUCTION

Helicobacter pylori (H. pylori) infection is now recognized as the cause of type B gastritis, as a critical factor in the development and the recurrence of duodenal ulcer disease, and as an essential co-factor in the development of gastric carcinoma and gastric MALT-lymphoma^1–5). Although estimation of the lifetime risk of developing an ulcer in people with H. pylori infection is difficult, it is believed that approximatley 10 – 15 % of individuals with H. pylori infection may develop an ulcer.^{6, 7)} The link between H. pylori and the development of peptic ulcer disease may be related to the inappropriate release of gastrin observed in H. pylori-positive patients. One of the most notable H. pylori-associated changes in gastric secretion is an increased gastrin release after meals and after bombesin stimulation. This abnormality is alleviated following eradication of the infection^8–14). It has also been shown that H. pylori infection can induce reversible increased basal and gastrin mediated acid secretion^{15, 16)}.

The mechanism by which H. pylori enhances gastrin release is not yet known but there have been increasing numbers of studies which show that changes in the numbers of antral G-cells and D-cells are responsible for the physiologic regulation of gastrin and gastric acid secretion. Many of the studies have suggested that H. pylori infection results in reduction of the number of antral D-cells and in the soamatostatin level resulting in a lack of inhibition of G-cells which leads to an increased amount of gastrin in the antrum and the serum.17–19 The purpose of this study was to evaluate the influence of H. pylori infection on the behaviour of the G-cell and D-cell populations and on the relationship between the serum gastrin concentration and the G-cell to D-cell ratio.

METHODS

Study Population

The study population consisted of 37 patients with infection and 33 patients without H. pylori infection. All of the 70 patients were either endoscopically and histologically confirmed benign gastric(GU) or duodenal ulcers (DU). Among H. pylori-positive patients, 29 patients had DU and 8 had GU. H. pylori-negative patients were divided as 22 DU and 11 GU patients. None of them had received H₂-receptor antagonists, antibiotics, proton pump inhibitors or NSAIDs for at least 30 days prior to biopsy. Patients with any other chronic illness were also excluded.

Methods

Four gastric mucosal specimens were obtained from the antrum within 3 cm proximal to the pylorus. Two of the specimens were examined for identification of H. pylori and the other two were evaluated for the numbers of G-cells and D-cells. Patient selection criteria included subjects with two good histologic specimens which contained the entire section from the surface epithelium to the muscularis mucosae. The presence of H. pylori infection was confirmed by H & E staining, culture, and histologic examination of biopsy specimens. For measurement of the serum gastrin concentration, a blood sample was collected after overnight fast from each patient. Fasting gastrin concentrations were measured by the radioimmunoassay technique using a Gamm Dab[¹²⁵I] Gastrin RIA kit (INCSTAR Co. UK) which specifically measures both G17 and G34. Results were expressed as ng/ml G17 equivalents. Each examination was duplicated.

Evaluation of Antral G-Cells and D-Cells

Gastric mucosal biopsy specimens were fixed in 10% buffered formalin and embedded in paraffin after routine dehydration and cleansing. Sections 5μm in thickness perpendicular to the surface of the mucosa, including a complete glandular portion and intact muscularis mucosae, were subjected to immunoperoxidase staining.

A complete glandular profile was defined as a gland totally within the microscopic field with a clearly visible lumen. For gastrin immunocytochemistry, the tissues were incubated overnight with rabbit antibiodies against the non-sulfated form of gastrin-17 (DAKO Corp., Copenhagen, Denmark). For somatostatin immunocytochemistry, the tissues were incubated with a polyclonal antibody raised against synthetic somatostatin (DAKO Corp., Copenhagen, Denmark). The secondary system in both cases consisted of an anti-rabbit ABC (avidin-biotin complex) kit (Biomeda Co., Foster). In both cases the reaction was developed with diaminobenzidine as the chromogen. Finally, the tissues were counterstained with H&E, then mounted.

Complete glandular profiles confined in the 7×7 grids of an eyepiece micrometer (Eyepiece Micrometer 20,4 OCM 7/7 SQ, Olympus Co., Japan) were selected and examined under a 40x objective for observation and quantitation of G-cells and D-cells. The total numbers of G-cells and D-cells in an entire grid square, including the nucleus in the plane section, were counted and the mean number of cells per millimeter of muscularis mucosae was calculated. All microscopic examinations were performed blindly by a pathologist unaware of either the individual serum gastrin level or the status of H. pylori infection.

Statistical Analysis

Results were expressed as the means±SD. A two-tailed, unpaired t-test and a Wilcoxon rank sum test were used to determine the significance of difference between means, with differences giving a p value less than 0.05 being considered significant. The number of each peptide-producing cell per gastric gland was calculated by dividing the total number of each cell type by the number of complete gland profiles counted from the same subject. The G-cell to D-cell ratio was calculated by dividing the numbers of G-cells by D-cells from the same subject, then averaging for the group.

RESULTS

Results are summarized in Table 1. There was no significant difference in the number of complete gastric gland profiles per field between patients with and without H. pylori infection. (9.8±2.7 vs 9.0±2.9, respectively, p>0.5).

Table 1.

Fasting Serum Gastrin Concentrations and Immunohistochemical Results for G-cells and D-cells

Serum Gastrin Concentration

The fasting serum gastrin concentration was significantly higher in patients with H. pylori infection compared to patients without infection (80.3±23.5 vs 47.6±14.1 pg/ml, respectively, p<0.001) (Fig. 1). There were no differences in serum gastrin concentration between GU and DU patients within both the H. pylori-infected group (81.6±18.8 vs 80.0±24.9, respectively, p>0.5) and the H. pylori-uninfected group (44.7±10.5 vs 49.1±15.6, respectively, p>0.5).

Fig. 1.

The Concentration of Fasting Serum Gastrin in Patients with and without infection. (*p<0.001)

G Cells

The mean number of G-cells per gastric gland was similar in patients with and without H. pylori infection. (7.1±3.1 vs 7.3±3.9, respectively, p>0.5) (Fig. 2). There were no differences in the number of G-cells between GU and DU patients within both the infected group (8.6±4.3 vs 6.7±2.6, respectively, p>0.5) and the uninfected group (6.6±2.3 vs 7.7±4.5, p>0.5).

Fig. 2.

The Number of G cells per Gastric Gland in Patients with and without infection. (p<0.5)

D Cells

The mean number of D-cells per gastric gland was significantly lower in both GU and DU patients with H. pylori infection compared to patients without H. pylori infection (1.3±0.4 vs 2.5±1.7, respectively, p<0.001) (Fig. 3). There were no differences in the number of D-cells between GU and DU patients within both the H. pylori-infected group (1.3±0.4 vs 13.±0.4, respectively, p>0.5), and H. pylori-uninfected gruop (2.1±1.0 vs 2.6±2.0, respectively, p>0.5).

Fig. 3.

The Number of D cells per Gastric Gland in Patients with and without infection. (*p<0.001)

The Ratio of G-cells to D-Cells

The ratio of G-cells to D-cells was significantly higher in patients with H. pylori infection compared to patients without H. pylori infection (5.7±2.7 vs 3.5±1.9, p<0.001, respectively) (Fig. 4). There were no differences in the ratio between GU and DU patients within both the H. pylori-infected group (7.0±4.2 vs 5.3±2.0, respectively, p>0.5), and the H. pylori-uninfected group (3.5±1.6 vs 3.5±2.1, respectively, p>0.5).

Fig. 4.

The Ratio of G cell / D cell in Patients with and without infection. (*p<0.0001)

DISCUSSION

The pathogenetic mechanism of H. pyori-associated peptic ulcer diseases have not been proved yet. However it is well known that a direct cytopathic effect of the organism on either the gastric or the duodenal epithelium is not involved in the development of peptic ulcer diseases because H. pylori is a non-invasive microorganism. One of the most characteristic abnormalities in gastric secretion induced by H. pylori infection is increased gastrin release after meals or after bombesin stimulation; this abnormality restored to its original state following eradication of the organism^8–14). It has also been shown that H. pylori infection can induce reversible increased both basal and gastrin-mediated acid secretion^{15, 16)}. However, the mechanism by which the microorganism alters gastrin metabolism is still unclear. Since synthesis and secretion of somatostatin, which is a physiologic paracrine inhibitor of antral G-cell function, are directly regulated by the intragastric pH, there is substantial evidence that the increased gastrin secretion of H. pylori-positive patients is related to an interplay between antral G-cells and D-cells. Therefore, we measured the numbers of antral G-cells and D-cells and correlated these numbers with serum gastrin concentrations in both H. pylori-infected and H. pylori-uninfected patients.

Our study showed that the number of complete gastric gland profiles was not different between patients with and without H. pylori infection. The number of G-cells per complete gastric gland was also not different between H. pylori-positive patients and -negative patients. Similar observations were made by Queiroz et al¹⁸⁾, Sankey et al²⁰⁾ and Moss et al²¹⁾, who demonstrated that the number of antral G-cells is apparently not affected by the presence of H. pylori. With regard to the serum gastrin concentration our results are in agreement with earlier studies which show that H. pylori-associated abnormalities in gastrin secretion are reversible with alleviation of the bacterial infection^{8–, 11, 13, 22–25)}.

There were also no differences in serum gastrin concentration between GU and DU patients within both the H. pylori-infected group and the H. pylori-uninfected group. In this study, the number of D-cells per complete gastric gland was significantly lower in both GU and DU patients with H. pylori infection compared to patients without infection. Consequently, the ratio of G-cells to D-cells was also significantly higher in H. pylori-positive patients than in H. pylori-negative patients. There were no differences in the ratio between GU and DU patients within both the H. pylori-infected group and H. pylori-uninfected group. Similar results have also been reported^{17, 18, 26, 27)}.

The mechanism by which H. pylori decreases the number of antral D-cells should be considered. One possible explanation is an inflammatory change in the region of the D-cells. Recently, Kaneko H. et al¹⁷⁾ and Moss et al¹⁹⁾ have reported that H. pylori infection is associated with a decrease in somatostatin-mRNA and is associated with the somatostatin-immunoreactive cell density of the antral mucosa. These changes were reversed after eradication of H. pylori. The degree of reversal was correlated with the grade of chronic inflammation. These findings are consistent with the reports of Domschke et al²⁸⁾ and Sumii et al²⁶⁾. Ito et al²⁹⁾ also reported that the number of D-cells decreased in proportion to the extent and degree of chronic atrophic gastritis, and that D-cells disappeared earlier and more diffusely than G-cells. Another possibilty may be a local alkaline environment induced by ammonia which is produced by bacterial urease. This possibility is supported by previous studies^30–34). These reports indicate that changes in intragastric acidity exert an influence on the antral D-cell density, on the tissue content of soamtostatin and on both the plasma and the antral gastrin concentration. Recently, there have been new efforts to explain the mechanism of increased gastrin release which is observed in patients with H. pylori infection. Graham et al³⁵⁾ observed that the number of G-cells was significantly lower in patients with DU than in either infected or uninfected controls, and that the ratio of G-cells to D-cells was similar in duodenal ulcer patients and in uninfected controls. They also found that, although eradication of the H. pylori infection results in a dramatic reduction in stimulated gastrin secretion, infection was not associated with a change in the number of either antral G-cells or D-cells in patients with DU. Based on these results they concluded that an H. pylori-associated increase in gastrin secretion appears to be related to local factors which regulate G-cell function. There are several reports regarding the role of cytokines, which are released by the inflammatory cells activated by H. pylori, in the regulation of antral G-cell function. These reports have suggested that interleukins, TNF-α or interferons stimulate gastrin secretion via receptors potentially residing on antral G-cells^36–38).

In conclusion, our results strongly suggest that the exaggerated response of gastrin secretion observed in H. pylori-positive patients is due to a reduction of the antral D-cell mass because these cells normally inhibit the synthesis and release of gastrin.

References

1. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterol 94:33–40. 1988;

2. Graham DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 6:105–113. 1991;

3. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol. Clin N Am 22:89–104. 1993;

4. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Issacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–1176. 1991;

5. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de-Boni M, Issacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575–577. 1993;

6. Cullen DJE, Collins BJ, Christiansen KJ, Epis J, Warren JR, Cullen KJ. Long term risk of peptic ulcer disease in people with H. pylori infection – a community based study. Gastroenterol 104:A60. 1993;

7. Sipponen P, Varis K, Fraki O, Dorri UM, Seppala K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer patients with or without chronic gastritis: a clinical follow-up study of 454 outpatients. Scand J Gastroenterol 25:996–973. 1990;

8. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1:1167–1168. 1989;

9. McColl KEL, Fullarton GM, el Nujumi AM, McDonald AM, Brown IL, Hilditch TE. Lowered gastrin and gastric acididty after eradication of Campylobacter pylori in duodenal ulcer. Lancet 2:499–500. 1989;

10. Levi S, Beardshall K, Swift I, Foulkes W, Playford R, Ghosh P, Calam J. Antral Helicobacter pylori, hypergastrinemia and duodenal ulcers: effect of eradicating the organism. BMJ 299:1504–1505. 1989;

11. Graham DY, Opekun A, Lew GM, Evans DJ Jr, Klein PD, Evans DG. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 85:394–398. 1990;

12. Prewett EJ, Smith JT, Nwokolo CU, Hudson M, Sawyerr AM, Pounder RE. Eradiaction of Helicobacter pylori abolishes 24-hour hypergastrinemia: a prospective study in healthy subjects. Aliment Pharmacol Therp 5:283–293. 1991;

13. McKoll KE, Fullarton GM, Chittajallu R, el Nujumi AM, McDonald AM, Dahill SW, Hilditch TE. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 26:339–346. 1991;

14. Graham DY, Opekun A, Lew GM, Klein PD, Walsh JH. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterol 100:1571–1575. 1991;

15. EI-Omar E, Penman I, Dirrian CA, Ardil JES, McColl KEL. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patientrs with duodenal ulcer. Gut 34:1060–1065. 1993;

16. Peterson WL, Barnett CC, Evans DJ Jr, Feldman M, Carmody T, Richardson C, Walsh J, Graham DY. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol 88:2038–2043. 1993;

17. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340:930–932. 1992;

18. Queiroz DMM, Mendes EN, Rocha GA, Moura SB, Resende LMH, Barbosa AJA, Coelho LGV, Pass MCE, Castro LP, Oliveira CA, Lima GF. Effects of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 28:858–864. 1993;

19. Kaneko H, Nakada K, Mitsuna T, Uchida K, Furusawa A, Maeda Y, Morise K. Helicobacter pylori infection induces a decrease in concentrations of human stomach. Dig Dis Sci 37:409–416. 1992;

20. Sankey EA, Helliwell PA, Dhillon AP. Immunostaining of antral gastrin cells is quantitatively increased in Helicobacter pylori gastritis. Histopathology 23:970–977. 1990;

21. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340:930–932. 1992;

22. Oderada G, Vaira D, Holton J, Ainley F, Anasaldi N. Amoxycillin and tinidazole for Campylobacter pylori gastritis in children: assessment of serum IgG antibody, pepsinogen I and gastrin levels. Lancet 1:690. 1989;

23. Chittajallu RS, Dorrian CA, Neuthercut WD, McColl KEL. Is helicoabcter associated hypergastrinemia due to bacterium’s urease activity or the antral gastritis. Gut 32:1286–1290. 1991;

24. Chittajallu RS, Neuthercut WD, MacDonald AMI, McColl KEL. Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentration. Gut 32:21–24. 1991;

25. Nujumi AME, Dorrian CA, Chittajallu RS, Neuthercut WD, McColl KEL. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut 32:866–870. 1991;

26. Sumii M, Sumii K, Tari A, Kawaguchi H, Yamamoto G, Takehara Y, Fukino Y, Kamiyasu T, Hamada M, Tsuda T, Yoshihara M, Haruma K, Kajiyama G. Expression of antral gastrin and somatostatin mRNA in Helicobacter pylori-infected subjects. Am J Gastroenterol 89:1515–1519. 1994;

27. Odum L, Peterson HD, Andersen IB, Hansen BF, Rehfeld JF. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 35:615–618. 1994;

28. Domschke S, Bloom SR, Adrian TE, Lux G, Bryant MG, Domschke W. Gastroduodenal mucosal hormone content in duodenal ulcer disease. Hepatogastroenterol 32:198–201. 1985;

29. Ito H, Tahara E. Immunohistochemical study on G and D cells in the human resected stomach with peptic ulcer disease. In : Miyoshi A, ed. Gut Peptide and Ulcer Biomedical Research Foundation. Tokyo: p. 180–187. 1982.

30. Arnold R, Hulst MV, Neuhof CH, Schuarting H, Becker HD, Creutzfeldt W. Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. Gut 23:285–291. 1982;

31. Brand SJ, Stone D. Reciprocal regulation of antral gastrin and soamatostatin gene expression by omeprazole-induced achlorhydria. J Clin Invest 82:1059–1066. 1988;

32. Karnik PS, Monahan SJ, Wolfe MM. Inhibition of gastrin gene expression by soamatostatin. J Clin, Invest 83:367–372. 1989;

33. Wu SV, Giraud A, Mogard M, Sumii K, Walsh JH. Effects of inhibition of gastric secretion on antral gastrin and somatostatin gene expression in rats. Am J Physiol 258:G788–793. 1990;

34. Wu SV, Sumii K, Tari A, Mogard M, Walsh JH. Regulation of gastric soamtostatin gene expression. Metabolism 9:125–130. 1990;

35. Graham DY, Lew GM, Lechago J. Antral G-cell and D-cell in Helicobacter pylori infection: effect of H. pylori eradication. Gastroenterol 104:1655–1660. 1993;

36. Kramling HJ, Enders G, Teichmann RK, Demmel T, Merkle R, Brendel W. Antigen-induced gastrin release: An immunologic mechanism of gastric antral mucosa. Adv Exp Med Biol 216A:427–429. 1987;

37. Golodner EH, Territo MC, Walsh JH, Soil AH. Stimulation of gastrin release from cultured canine G cells by Helicobacter pylori and mononuclear cells. Gastroenterol 102:A630. 1992;

38. Weigert N, Schaffer K, Schusdziarra V, Classen M, Schepp W. Gastrin secretion from primary cultures of rabbit antral G cells: stimulation by inflammatory cytokines. Gastroenterol 110:147–154. 1996;

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Group (n)	Serum Gastrin Concentration^*	Number of G-cells^**	Number of D-cells^**	Ratio of G-cells to D-cells
With H. pylori (37)	80.3±23.5^a	7.1±3.1	1.3±0.4^b	5.7±2.7^c
Gastric Ulcer (8)	81.6±18.8	8.6±4.3	1.3±0.4	7.0±4.2
Duodenal Ulcer (29)	80.0±24.9	6.7±2.6	1.2±0.4	5.3±2.0

Without H. pylori (33)	47.6±14.1^a	7.3±3.9	2.5±1.6^b	3.5±1.9^c
Gastric Ulcer (11)	44.7±10.5	6.6±2.3	2.1±1.0	3.5±1.6
Duodenal Ulcer (22)	49.1±15.6	7.7±1.9	2.6±1.9	3.5±2.1